Stay updated on Semaglutide Dose Response Study in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Semaglutide Dose Response Study in Type 2 Diabetes Clinical Trial page.

Latest updates to the Semaglutide Dose Response Study in Type 2 Diabetes Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new revision label, Revision: v3.4.2, was added to the record history, and a government funding notice (and the prior v3.4.1 entry) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check21 days agoChange DetectedA global notice about government funding was added at the top of the page, and the site revision label updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check28 days agoChange DetectedThe history page now includes a glossary and uses color-coded highlights for changes (green for additions, red for deletions). The revision line updates to v3.4.0 and the 'No FEAR Act Data' text is adjusted.SummaryDifference0.9%

- Check42 days agoChange DetectedAdded Revision: v3.3.4 to the Record History. Removed Revision: v3.3.3 from the Record History.SummaryDifference0.1%

- Check64 days agoChange DetectedThe record history gained a new entry 'Revision: v3.3.3' and the items 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' were removed.SummaryDifference0.2%

- Check71 days agoChange DetectedVersion 14 adds Contacts/Locations and Study Status sections to the Record History page on 2025-12-12. A deletion occurred on 2024-11-05.SummaryDifference0.5%

Stay in the know with updates to Semaglutide Dose Response Study in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Semaglutide Dose Response Study in Type 2 Diabetes Clinical Trial page.